非缺血性扩张型心肌病中比较心脏磁共振标测方法与心肌模式对心力衰竭结局的预测
本研究在240例非缺血性扩张型心肌病患者中,比较延迟钆增强(LGE)、原生T1、分配系数(λGd)和细胞外容积分数(ECV)标测对主要不良心脏事件(MACE)的预后价值。中位随访3.8年,36例(15%)发生MACE;平均ECV和λGd均与MACE强相关(均p < 0.001),ECV所有6个解剖位置均与MACE和死亡相关,其中前间隔最显著(p < 0.0001)。平均ECV是唯一进入包含年龄、性别、NYHA心功能分级和左心室射血分数预后模型的预测因子,每增加10%调整后MACE风险增加2.8倍(p < 0.001)。
要点
- 在非缺血性扩张型心肌病中,ECV标测的所有6个位置均与MACE和死亡相关,前间隔最显著(p < 0.0001)。
- 平均ECV每增加10%,调整后MACE风险增加2.8倍(p < 0.001)。
- 异常ECV位置数量与年MACE发生率呈线性相关(p = 0.0003)。
核心结论
- 在非缺血性扩张型心肌病患者中,使用ECV标测心肌异常范围对心力衰竭结局的预后价值优于LGE或原生T1标测。
研究设计与样本
- 研究纳入连续240例非缺血性扩张型心肌病患者(年龄49 ± 16岁;女性38%),采用Look-Locker cine梯度回波技术行T1标测,于对比剂注射前及注射后系列采集心肌和血池T1及对应R1值,由心肌与血池R1最小二乘回归线斜率得出λGd,再经血清血细胞比容调整得出ECV;标测6个解剖位置,并与结局关联。
诊断标准与关键数值
- 非缺血性LGE检出率为34%,ECV升高(≥1个位置)者为58%;平均ECV和λGd均与MACE强相关(均p < 0.001);ECV所有6个位置均与MACE和死亡相关,前间隔最显著(p < 0.0001);异常ECV位置数量与年MACE发生率线性相关(p = 0.0003);平均ECV每增加10%,调整后MACE风险增加2.8倍(p < 0.001)。
临床应用与阅片要点
- 在非缺血性扩张型心肌病患者的CMR报告中,可结合ECV标测(包括各解剖位置及异常位置数量)提供预后信息,其预后价值优于LGE或原生T1标测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: In patients with nonischemic dilated cardiomyopathy (NIDCM), native T1, partition coefficient (λGd), and extracellular volume fraction (ECV) mapping may offer prognostic values beyond late gadolinium enhancement (LGE), by scaling the range of myocardial changes.
BACKGROUND: In patients with NIDCM, LGE is seen in 30% of patients and it indicates adverse prognosis.
METHODS: The study mapped 6 anatomical locations using all 4 cardiac magnetic resonance (CMR) tissue-characterizing methods and associated with outcome. The authors performed T1 mapping of the myocardium and the blood pool, before and serially after contrast injection, using a Look-Locker cine gradient-echo technique to obtain T1 and the corresponding reciprocal R1 values. λGd values were derived from the slopes of the least-squares regression lines for myocardial versus blood R1, then adjusted to serum hematocrit to yield ECV.
RESULTS: Consecutive 240 NIDCM patients (49 ± 16 years of age; 38% women) underwent CMR for cardiac function, LGE, native T1, λGd, and ECV. After a median of 3.8 years, 36 (15%) experienced major adverse cardiac events (MACE), including 22 heart failure hospitalizations and 14 deaths. Nonischemic LGE was detected in 34%, whereas ECV was elevated (≥1 location) in 58%. Comparing the 4 methods, mean ECV and λGd both demonstrated strong association with MACE (both p < 0.001). In contrast to native T1 and LGE, ECV values from all 6 locations were associated with MACE and death, with the anteroseptum being the most significant (p < 0.0001). The number of abnormal ECV locations correlated linearly with annual MACE rates (p = 0.0003). Mean ECV was the only predictor to enter a prognostic model that contained age, sex, New York Heart Association functional class, and left ventricular ejection fraction. For every 10% increase, mean ECV portended to a 2.8-fold adjusted increase risk to MACE (p < 0.001).
CONCLUSIONS: In this study of patients with NIDCM, mapping the myocardial extent of abnormality using ECV offers prognostication toward heart failure outcomes incremental to LGE or native T1 mapping.
引用
- Vita T, Gräni C, Abbasi SA, et al. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2018. PMID: 30448130. doi:10.1016/j.jcmg.2018.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。